Calibre is a London-based healthtech company founded in 2025, pioneering the category of Causal Health Navigation. Its proactive health membership combines diagnostics, clinical expertise, and causal AI to help people understand their health and exactly how to change it. The UK is Calibre’s initial launch market, with plans to expand internationally in the future. The company has applied to become a CQC-regulated provider in the UK
where all clinical care is currently delivered by its partner DocTap, a CQC-registered
provider.
Calibre: Venture Capital Funding History
Calibre
Calibre
- Health
- London, United Kingdom
- £2.4m
- getcalibre.com
- Update Information
More venture news
- 30 Sept 2026

Inovus MedicalInovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training
EquityHealth - 29 Sept 2026

DYADDYAD secures a £7.5m Series A led by Sangha Capital for its system that converts clinical documents into structured data for GP patient records
Series AHealth - 24 Sept 2026

IMS SolutionsIMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS
SeedHealth
